Tradestie Institutional Equity Comparison Engine

MXCT vs LZAGY โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MXCT Overall Edge

MXCT Captures Institutional Edge (2โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MaxCyte, Inc. Common Stock (MXCT) driven by superior Growth & Margin, Options & Structure while LZAGY counters with relative strength in Momentum & Technical. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus LZAGY at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LZAGY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
MXCT N/M vs LZAGY N/M Fwd P/E
Growth & Margin Winner MXCT
Op Margin -85.5% vs N/A ยท YoY +48.7% vs N/A
Momentum & Technical Winner LZAGY
1Y -19.4% vs +16.5% ยท 52W Pos 63% vs 77%
Options & Structure Winner MXCT
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MXCT NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap $132.2M
1M Return -4.2%
1Y Return -19.41%
Forward P/E N/M
Unified AI Score
41.7 / 100 SELL
Tech 46.0 Fund 52.0 Flow 62.0 Mom 50.0
LZAGY US Equity
LZAGY
Institutional Equity
$77.10
-2.58% 1D
Market Cap N/A
1M Return +0.53%
1Y Return +16.54%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 18.0 Fund 39.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MXCT -19.41% LZAGY +16.54% Spread: +35.95 pp (LZAGY Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MXCT TTM Op. Margin: -85.5% LZAGY TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MXCT vs LZAGY. Trailing 12-month operating profitability (MXCT -85.5% vs LZAGY N/A) and valuation multiples (MXCT N/M vs LZAGY N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MXCT (5) vs LZAGY (3)
Institutional Metric MXCT LZAGY Criterion Row Winner
Market Capitalization Scale $132.2M N/A Larger Scale MXCT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +48.7% N/A Higher Growth MXCT
Operating Margin (TTM) Profitability -85.5% N/A Higher Margin MXCT
Net Profit Margin Profitability -81.4% N/A Higher Margin MXCT
Return on Equity (ROE) Capital Efficiency -16.9% N/A Higher ROE MXCT
52-Week Range Position Momentum 63% ($1โ€“$2) 77% ($59โ€“$83) Stronger Trend LZAGY
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 96% Vol 0.45ฮฒ ยท 17% Vol Lower Realized Risk LZAGY
Unified Institutional Score Composite Signal 41.7 / 100 (SELL) 44.5 / 100 (HOLD) Higher Composite LZAGY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MXCT vs LZAGY Buy Guide
MXCT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MXCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LZAGY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LZAGY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MXCT nor LZAGY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.